Sabutoclax
Catalog No. A12823
Sabutoclax (BI-97C1)是pan-Bcl-2抑制剂,包括Bcl-xL,Bcl-2,Mcl-1和Bfl-1,IC50分别为0.31 μM,0.32 μM,0.20 μM和0.62 μM。
- Christopher D. Graham, .et al. BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells, Oncotarget, 2017, Jan 31; 8(5): 8670-8678 PMID: 28055968
Catalog Num | A12823 |
---|---|
M. Wt | 700.78 |
Formula | C42H40N2O8 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1228108-65-3 |
Synonyms | BI-97C1,BI97C1 |
SMILES | CC1=C(C(=C2C=C(C(=C(C2=C1)C(=O)NC[C@H](C)C3=CC=CC=C3)O)O)O)C4=C(C=C5C(=C4O)C=C(C(=C5C(=O)NC[C@H](C)C6=CC=CC=C6)O)O)C |
Sabutoclax (BI-97C1)是pan-Bcl-2抑制剂,包括Bcl-xL,Bcl-2,Mcl-1和Bfl-1,IC50分别为0.31 μM,0.32 μM,0.20 μM和0.62 μM。
Targets
Mcl-1 | Bcl-xL | Bcl-2 | Bfl-1 | |
0.20 μM | 0.31 μM | 0.32 μM | 0.62 μM |
In vitro | DMSO | Warmed: 93 mg/mL (132.7 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 50 mg/mL (71.34 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 14.27 mL | 71.35 mL | 142.7 mL |
0.5 mM | 2.85 mL | 14.27 mL | 28.54 mL |
1 mM | 1.43 mL | 7.13 mL | 14.27 mL |
5 mM | 0.29 mL | 1.43 mL | 2.85 mL |
*The above data is based on the productmolecular weight 700.78. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.